261 related articles for article (PubMed ID: 15964421)
21. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
[TBL] [Abstract][Full Text] [Related]
22. [Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)].
Weigao C
Fukuoka Igaku Zasshi; 1996 Sep; 87(9):197-205. PubMed ID: 8913057
[TBL] [Abstract][Full Text] [Related]
23. Limb transplantation in rats: immunosuppression with FK-506.
Min Z; Jones NF
J Hand Surg Am; 1995 Jan; 20(1):77-87. PubMed ID: 7536766
[TBL] [Abstract][Full Text] [Related]
24. Prolonged survival of rat hindlimb allografts following short-course FK506 and mycophenolate mofetil combination therapy.
Song YX; Muramatsu K; Kurokawa Y; Taguchi T
Microsurgery; 2005; 25(4):353-9. PubMed ID: 15880483
[TBL] [Abstract][Full Text] [Related]
25. Limb allotransplantation in the rat: extended survival and return of nerve function with continuous cyclosporin/prednisone immunosuppression.
Press BH; Sibley RK; Shons AR
Ann Plast Surg; 1986 Apr; 16(4):313-21. PubMed ID: 3273049
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
27. Donor-derived transplant acceptance-inducing cells in composite tissue allotransplantation.
Radu CA; Horn D; Kiefer J; Rebel M; Gebhard MM; Ryssel H; Köllensperger E; Fändrich F; Germann G; Kremer T
J Plast Reconstr Aesthet Surg; 2012 Dec; 65(12):1684-91. PubMed ID: 22841770
[TBL] [Abstract][Full Text] [Related]
28. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
[TBL] [Abstract][Full Text] [Related]
29. Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat.
Jiang W; Jiang J; Xu D; Wang X; Qi S; Ouyang J; Ma A; Vu MD; Bilolo KK; Chen H
Microsurgery; 2003; 23(2):117-22. PubMed ID: 12740883
[TBL] [Abstract][Full Text] [Related]
30. Peripheral nerve allograft transplantation with FK506: functional, histological, and immunological results before and after discontinuation of immunosuppression.
Büttemeyer R; Rao U; Jones NF
Ann Plast Surg; 1995 Oct; 35(4):396-401. PubMed ID: 8585683
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival.
Kuroki H; Bean MA; Ikuta Y; Burgess EM
Transplant Proc; 1991 Dec; 23(6):3282-4. PubMed ID: 1721436
[No Abstract] [Full Text] [Related]
33. Peripheral donor leukocytes prolong survival of rat renal allografts.
Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G
Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380
[TBL] [Abstract][Full Text] [Related]
34. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
Fang YH; Joo DJ; Lim BJ; Huh KH; Kim MS; Suh H; Kim YS
J Surg Res; 2011 Nov; 171(1):e133-7. PubMed ID: 21816421
[TBL] [Abstract][Full Text] [Related]
35. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
[TBL] [Abstract][Full Text] [Related]
36. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
[TBL] [Abstract][Full Text] [Related]
37. Experimental study of combined treatment with tacrolimus and donor splenocytes via the portal vein in small bowel transplantation.
Miyauchi T; Ishikawa M; Tashiro S; Hisaeda H; Himeno K
J Med Invest; 2001 Aug; 48(3-4):157-65. PubMed ID: 11694955
[TBL] [Abstract][Full Text] [Related]
38. Prolonged survival of vascularized limb tissue allografts by donor irradiation.
Lee WP; Randolph MA; Weiland AJ; Yaremchuk MJ
J Surg Res; 1995 Nov; 59(5):578-88. PubMed ID: 7475004
[TBL] [Abstract][Full Text] [Related]
39. Recipient FK506 pretreatment regimens in rat small bowel transplantation: allograft survival, function, and systemic infection.
Guo WH; Tian L; Yuen ZW; Chan KL; Wo JY; Nicholls G; Dallman M; Tam PK
J Pediatr Surg; 2000 Nov; 35(11):1600-5. PubMed ID: 11083432
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506.
Fabrega AJ; Blanchard JM; Rivas PA; Pollak R
Transplantation; 1993 Dec; 56(6):1579-80. PubMed ID: 7506458
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
